Royalty Pharma Plc Cl A (RPRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
33.70 +0.20 (+0.60%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.85 +0.15 (+0.45%) 19:29 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | 1,330,813 | 996,462 | 190,104 | -4,273 | 1,700,088 |
Depreciation Amortization | 19,562 | 14,256 | 8,908 | 4,349 | 20,499 |
Accounts receivable | -4,551 | -2,496 | -1,175 | 178 | -1,521 |
Other Working Capital | 887,371 | 620,220 | 380,501 | 173,908 | 1,009,038 |
Other Operating Activity | 535,791 | 398,019 | 744,509 | 490,476 | 259,698 |
Operating Cash Flow | $2,768,986 | $2,026,461 | $1,322,847 | $664,638 | $2,987,802 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -2,505,701 | -18,000 | -18,000 | N/A | -2,115,522 |
PPE Investments | -18,000 | -2,009,283 | -814,712 | -86,084 | N/A |
Purchase Of Investment | -298,455 | -273,455 | -260,955 | -6,971 | -24,942 |
Sale Of Investment | 142,002 | 126,172 | 111,803 | 6,405 | 69,713 |
Other Investing Activity | 2,039 | 2,039 | 2,038 | 0 | -2,038 |
Investing Cash Flow | $-2,678,115 | $-2,172,527 | $-979,826 | $-86,650 | $-2,072,789 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 350,000 |
Debt Issued | 1,471,235 | 1,471,235 | 1,471,235 | N/A | N/A |
Debt Repayment | N/A | N/A | N/A | N/A | -1,000,000 |
Common Stock Issued | 5,107 | 3,856 | 2,596 | 1,426 | 7,476 |
Common Stock Repurchased | -229,651 | -177,044 | -79,999 | N/A | -304,759 |
Dividend Paid | -863,904 | -657,598 | -430,964 | -213,424 | -854,848 |
Other Financing Activity | -21,642 | -21,341 | -18,255 | 0 | -346,623 |
Financing Cash Flow | $361,145 | $619,108 | $944,613 | $-211,998 | $-2,148,754 |
Beginning Cash Position | 477,010 | 477,010 | 477,010 | 477,010 | 1,710,751 |
End Cash Position | 929,026 | 950,052 | 1,764,644 | 843,000 | 477,010 |
Net Cash Flow | $452,016 | $473,042 | $1,287,634 | $365,990 | $-1,233,741 |
Free Cash Flow | |||||
Operating Cash Flow | 2,768,986 | 2,026,461 | 1,322,847 | 664,638 | 2,987,802 |
Capital Expenditure | -18,000 | -2,009,283 | -814,712 | -86,084 | N/A |
Free Cash Flow | 2,750,986 | 17,178 | 508,135 | 578,554 | 2,987,802 |